Notice ID: 4ff1c587b4144eed968763c38572d996Combined Synopsis/Solicitation
Amendment #0001 | Overlapping Peptide Library of Rabies Envelope Glycoprotein and HPV (L1) Capsid L1 Protein
Archived on September 15, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM UTC−04:00
- Posted
- August 29, 2023
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NIH NCI
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- 75N91023Q00144
- Notice ID
- 4ff1c587b4144eed968763c38572d996
Description
See attached combined synopsis solicitation that includes instructions on how to submit quotes for any interested offeror. Amendment #0001 - RFQ Response date is hereby extended until 08/31/2023.
Award Overview
No prior contract identified
No matching prior contract was found within an 18-month window using the same agency, NAICS, place-of-performance state, and PSC. This may be a new requirement, or the prior award uses a different classification.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N91023Q00144- Combined Synopsis
- 2×Combined SynopsisCurrentAug 25, 2023
Amendment #0001 | Overlapping Peptide Library of Rabies Envelope Glycoprotein and HPV (L1) Capsid L1 Protein
Similar Opportunities
Title | Phase | Deadline |
|---|---|---|
Additional Details
Solicitation Number
75N91023Q00144
Archive Date
Sep 15, 2023
Office Address
Bethesda, MD, 20892